News Summary: J&J predicts surge of new medicines

News Summary: J&J plans to seek approvals of many new medicines, twists on old ones, by 2017

Associated Press

BIG PLANS: Johnson & Johnson says it's poised by 2017 to seek regulatory approval for a dozen new medicines and two dozen variations of existing ones.

BIG IMPACT: Two experimental medicines could transform current treatments. One is an antidepressant that appears to work in just a day, instead of taking weeks. The other is a powerful painkiller that's not addictive.

BIG REBOUND: J&J has recovered from a sales drop in 2009, fueled by the launch of 11 new products since then. Last year, those drugs brought in about one-sixth of J&J's $25.4 billion in total pharmaceutical sales.

View Comments (0)